Pulling SEC filings + quote and writing the call…

iRhythm Holdings, Inc.
Next earnings Jul 29, 2026 · consensus $0.00 EPS, $224M rev
Last earnings +7.0% on 2026-04-30
Inflection toward profitability is real — 26% growth, 70.6% gross margin, OCF up 23x — but still loss-making and not cheap at 4.9x sales.
Sources: SEC EDGAR (CIK 0001388658, latest 10-Q filed 2026-04-30) · EODHD · analysis by claude-code · as of 6/25/2026, 1:27:56 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
iRhythm is finally showing operating leverage on its Zio ambulatory cardiac monitoring franchise. FY2025 revenue grew 26.2% to $747M with a 70.6% gross margin, net loss narrowed 60.7% to -$44.6M, and operating cash flow exploded from ~$3M to $80.9M (+2,285%). The MD&A confirms a diversified payor mix — 52% contracted third-party, 24% CMS, 17% healthcare institutions — and the company has delivered 12M+ patient reports across nearly 3 billion hours of curated ECG data, which is a defensible data moat for the FDA-cleared/CE-marked patch + cloud analytics platform.
The risks, catalysts, 12-month price target and the cited SEC figures behind this rating — with Pro.
Unlock with Pro€15/mo · cancel anytime
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $323M | $411M | $493M | $592M | $747M |
| Gross profit | $214M | $282M | $332M | $408M | $527M |
| Operating income | -$99.9M | -$114M | -$125M | -$116M | -$57.4M |
| Net income | -$101M | -$116M | -$123M | -$113M | -$44.6M |
| Diluted EPS | -$3.46 | -$3.88 | -$4.04 | -$3.63 | -$1.39 |
| Net margin | -31.4% | -28.3% | -25.0% | -19.1% | -6.0% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosed a material cybersecurity incident under Item 1.05
Reg FD disclosure (investor/conference materials)
Annual meeting vote results and board/officer changes
Q1 2026 results continued top-line growth on the FY25 +26% trajectory
Q1 2026 results continued top-line growth on the FY25 +26% trajectory
2026 proxy: director slate, say-on-pay, auditor ratification
Change in the registrant's certifying accountant (auditor)
Executive officer transition with related Reg FD disclosure
FY25 rev $747M (+26%), net loss narrowed 61%, OCF jumped to $81M
Disclosed under the STOCK Act
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
1071 tracked peers · median
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
Last 90 days: 0 open-market buys · 2 sales
| 2026-06-02 | Shrishrimal Sumi EVP, Chief Risk Officer | Sell | 1.72K @ $108.19 | $186K |
| 2026-06-02 | Rosenbaum Marc Wade Chief Accounting Officer | Sell | 729.00 @ $108.19 | $78.9K |
| 2026-05-29 | Shrishrimal Sumi EVP, Chief Risk Officer | Award | 133.00 @ $96.82 | $12.9K |
| 2026-05-29 | Rosenbaum Marc Wade Chief Accounting Officer | Award | 178.00 @ $96.82 | $17.2K |
| 2026-05-29 | Turakhia Minang CHIEF MED/SCI OFCR EVP ADVTECH | Award | 137.00 @ $96.82 | $13.3K |
| 2026-05-29 | Patterson Chad CHIEF COMM & PRODUCT OFFICER | Award | 177.00 @ $96.82 | $17.1K |
| 2026-05-29 | Freeman Sean Clinton EVP, Strategy & Corp Devt | Award | 273.00 @ $96.82 | $26.4K |
| 2026-05-29 | Blackford Quentin S. President and CEO | Award | 178.00 @ $96.82 | $17.2K |
| 2026-05-27 | Bairey Merz Cathleen Noel Director | Award | 1.57K | |
| 2026-05-27 | Bodaken Bruce G. Director | Award | 1.57K |
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.